Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. (Q47299474)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2005
edit
Language Label Description Also known as
English
Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174.
scientific article published in January 2005

    Statements

    Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit